UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

Cancer research (Chicago, Ill.), 2014-06, Vol.74 (11), p.3137-3145

2014

Volltextzugriff (PDF)

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

British journal of pharmacology, 2016-03, Vol.173 (5), p.804-814

2016

Volltextzugriff (PDF)

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment

Therapeutic advances in medical oncology, 2022-03, Vol.14, p.17588359221081075-17588359221081075

2022

Volltextzugriff (PDF)

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2011-12, Vol.56 (5), p.1016-1023

2011

Volltextzugriff (PDF)

Influence of Darolutamide on Cabazitaxel Systemic Exposure

Clinical pharmacokinetics, 2022-10, Vol.61 (10), p.1471-1473

2022

Volltextzugriff (PDF)

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1055-1062

2011

Volltextzugriff (PDF)

Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2023-06, Vol.1225, p.123752-123752, Article 123752

2023

Volltextzugriff (PDF)

Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2009-12, Vol.50 (5), p.977-982

2009

Volltextzugriff (PDF)

The issue of non-specific binding of cabazitaxel

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-08, Vol.932, p.74-75

2013

Volltextzugriff (PDF)

Influence of darolutamide on cabazitaxel systemic exposure

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5038-5038

2022

Volltextzugriff (PDF)

Genome-wide association study for identification of candidate SNPs associated with carboplatin and paclitaxel clearance in ovarian cancer patients

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5563-5563

2014

Volltextzugriff (PDF)

Abstract A55: Influence of ABCB1 polymorphisms on paclitaxel pharmacokinetics in ovarian cancer patients

Clinical cancer research, 2013-10, Vol.19 (19_Supplement), p.A55-A55

2013

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Humans
(5)
Pharmacokinetics
(5)
Pharmacology & Pharmacy
(5)
Biological And Medical Sciences
(4)
Chemistry
(4)
Chemistry, Analytical
(4)
Lc-Ms/ms
(4)
Medical Sciences
(4)
Pharmacology. Drug Treatments
(4)
Physical Sciences
(4)
Chromatography, Liquid - Methods
(3)
Lc–ms/ms
(3)
Oncology
(3)
Analysis
(2)
Analytical, Structural And Metabolic Biochemistry
(2)
Animals
(2)
Antineoplastic Agents
(2)
Biochemical Research Methods
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Influence of Darolutamide on Cabazitaxel Systemic Exposure

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma

Validated bioanalytical method for the quantification of RGB-286638, a novel multi-targeted protein kinase inhibitor, in human plasma and urine by liquid chromatography/tandem triple-quadrupole mass spectrometry

The issue of non-specific binding of cabazitaxel

Influence of darolutamide on cabazitaxel systemic exposure

Genome-wide association study for identification of candidate SNPs associated with carboplatin and paclitaxel clearance in ovarian cancer patients

Abstract A55: Influence of ABCB1 polymorphisms on paclitaxel pharmacokinetics in ovarian cancer patients

Suchergebnisse filtern